A non-enzymatic wound debridement technology

‚Äč

  • Superior efficacy vs current drug therapy, supported by in-vitro and in-vivo studies

  • Broader spectrum of usage vs current drug therapy, supported by in-vitro and in-vivo studies

– Efficacy not impacted by pH

– Efficacy not impacted by presence of common topical antimicrobials

– Works on all types of necrotic material including fibrin, elastin and collagen

*This drug has not yet been approved by the FDA